用于选择性COX-2抑制和局部药物释放的奇拉性控制的甲联合体的设计
Srinivasa Rao Nelli1, Yue-Ming Xing1, Satish Kumar Talloj1
1Department of Materials Science and Engineering, National Yang Ming Chiao Tung University, No. 1001, Daxue Rd. East Dist., Hsinchu City, 300093, Taiwan, R. O. C.
Chemistry, an Asian journal
|June 9, 2025
概括
这项研究合成了Ketorolac-peptide结合物,增强了对COX-2的抗炎药物选择性. 合性合物Ket-Gly-D-Phe-D-Phe显示了改善的COX-2选择性,提供了更安全的治疗潜力.
科学领域:
- 药用化学 医学化学
- 超分子化学 超分子化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 像Ketorolac (Ket) 抑制循环氧化酶 (COX) 酶以减少疼痛和炎症.
- 凯托洛拉克的非选择性COX抑制可以引起不良影响.
- 提高COX-2选择性对于开发更安全的抗炎疗法至关重要.
研究的目的:
- 为了合成和分析具有可控性的Ketorolac-tripeptide结合物.
- 为了增强Ketorolac的COX-2选择性.
- 探索自我组装的超分子水凝在药物输送中的潜力.
主要方法:
- 合成两性凯托洛拉克封顶的联体.
- 控制的性被纳入了序列.
- 在水中自组合,在pH值7.0时形成超分子凝.
- 对合成化合物的COX-2/COX-1选择性比率的评估.
主要成果:
- 凯托洛拉克-三联合物自组装成超分子凝.
- 相比于Ketorolac,Ket-Gly-D-Phe-D-Phe表现出明显更高的COX-2选择性.
- -Gly-D-Phe-D-Phe实现了5.8的COX-2/COX-1比率,表明了增强的选择性.
- 大多数类的COX-2/COX-1比率低于1.
结论:
- 在Ketorolac衍生物中增强COX-2选择性时,性控制至关重要.
- 凯特-格莱-D-Phe-D-Phe代表了更安全的抗炎疗法的有希望的候选人.
- Ket-Gly-D-Phe-D-Phe的超分子水凝可能适用于局部和受控的药物释放应用,最大限度地降低全身毒性.
相关概念视频
Chirality in Nature
16.8K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
16.8K
Prochirality
4.9K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
4.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
597
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
597
Local Anesthetics: Chemistry and Structure-Activity Relationship
6.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.4K


